AB Science patent for masitinib in the treatment of sickle cell disease formally granted in the US with a protection until 2040

PRESS RELEASEAB SCIENCE PATENT FOR MASITINIB IN THE TREATMENT OF SICKLE CELL DISEASE FORMALLY GRANTED IN THE UNITED STATES WITH A PROTECTION ...

AB Science announces the initiation of coverage of its stock by Maxim Group with a target price of EUR 4.0 per share

PRESS RELEASEAB SCIENCE ANNOUNCES THE INITIATION OF COVERAGE OF ITS STOCK BY MAXIM GROUP WITH A TARGET PRICE OF EUR 4.0 PER SHAREParis, December ...
TipRanks on MSN

AB Science granted U.S. patnet for masitinib in treatment of SCD

AB Science (ABSCF) announced that the United States Patent Office has formally granted a patent for methods of treating sickle cell disease using ...
Hosted on MSN

AB Science Reports Key Developments and Financial Results

Ab Science ( (ABSCF)) has released its Q2 earnings. Here is a breakdown of the information Ab Science presented to its investors. Take advantage of TipRanks Premium at 50% off! Unlock powerful ...
Morningstar

AB Science receives Chinese patent protecting masitinib in the treatment of Covid-19 until 2041, adding one more indication with long term intellectual property protection

While AB Science believes these forward-looking statements are reasonable, investors are cautioned that these forward-looking statements are subject to numerous risks and uncertainties that are ...
Morningstar

AB Science receives regulatory approval from European countries to initiate third stage of Phase I/II study combining its molecule AB8939 with venetoclax for the treatment of AML

AB Science SA (Euronext - FR0010557264 - AB) today announced the approval of the third of four stages of the Phase I/II study (AB18001) with the compound AB8939 in adult patients with ...
Seeking Alpha

AB Science S.A. (ABSCF) Discusses Clinical Update on AB8939 Combined With Venetoclax for Refractory and Relapsed AML With Poor Genetics Transcript

Good morning, and good afternoon for the participant to our web conference organized by AB Science. About an update of the clinical development of our asset called AB8939. My name is Alain Moussy, I'm ...
Nasdaq

AB Science Receives Chinese Patent Protecting Masitinib To Treat Covid-19 Until 2041; Stock Up

(RTTNews) - French pharmaceutical company AB Science SA (ABSCF.PK) announced Monday that it has received Chinese patent protecting Masitinib in the treatment of Covid-19 until April 2041. In Paris, AB ...
Forbes

Augustinus Bader Launched A Skincare Line With Dua Lipa

DUA Skincare, backed by Dr. Bader’s famous AB Science, launched with three daily essentials: a cream cleanser, a complex serum, and an all-in-one daily moisturizer. ByTanya Akim, Contributor. Forbes ...